Success Metrics

Clinical Success Rate
100.0%

Based on 10 completed trials

Completion Rate
100%(10/10)
Active Trials
0(0%)
Results Posted
60%(6 trials)

Phase Distribution

Ph not_applicable
2
14%
Ph phase_1
4
29%
Ph phase_2
7
50%
Ph phase_4
1
7%

Phase Distribution

4

Early Stage

7

Mid Stage

1

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
4(28.6%)
Phase 2Efficacy & side effects
7(50.0%)
Phase 4Post-market surveillance
1(7.1%)
N/ANon-phased studies
2(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.9%

10 of 11 finished

Non-Completion Rate

9.1%

1 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Completed(10)
Terminated(1)
Other(3)

Detailed Status

Completed10
unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 14 (28.6%)
Phase 27 (50.0%)
Phase 41 (7.1%)
N/A2 (14.3%)

Trials by Status

withdrawn17%
completed1071%
unknown321%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
14